Gossamer Bio Inc. (GOSS) Misses Q3 EPS by 2c; Reports Cash and Cash Equivalents of $366.0M
Tweet
Share
E-mailGet Alerts GOSS Hot Sheet
Join SI Premium – FREE
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.80), $0.02 worse than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
